Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials

Overview of attention for article published in Drug Design, Development and Therapy, September 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy: 1 policy source

facebook: 1 Facebook page

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 55 Mendeley

Summary Policy documents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

日本がん対策新聞, 10 Oct 2015

【去勢抵抗性前立腺がん】骨転移例における放射性医薬品の有用性疼痛を軽減、生活の質を改善、骨関連イベントを抑制。ストロンチム-89およびラジウム223を用いた場合、生存期間も延長。〔Drug Des Devel Ther〕 http://www.ncbi.n…